会員登録
ログイン
【4575】キャンバス
創薬ベンチャー。抗がん剤を開発。
業績予想修正履歴
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023.06 | 2023/08/10 | 実 | 0 | - | - | - | -965 | ↓ | -0.7% | -0.7% | -1,283 | ↑ | +0.1% | +0.1% | -1,244 | ↑ | +0.1% | +0.1% |
| 2023.06 | 2023/07/03 | 当初予 | - | - | - | - | -958 | - | - | - | -1,284 | - | - | - | -1,245 | - | - | - |
| 2022.06 | 2022/08/12 | 実 | 0 | - | - | - | -846 | ↑ | +1.6% | +1.6% | -854 | ↑ | +2.0% | +2.0% | -855 | ↑ | +1.9% | +1.9% |
| 2022.06 | 2022/07/01 | 当初予 | - | - | - | - | -860 | - | - | - | -871 | - | - | - | -872 | - | - | - |
| 2021.06 | 2021/08/13 | 実 | 108 | - | - | - | -547 | - | - | - | -555 | - | - | - | -531 | - | - | - |
| 2020.06 | 2020/08/11 | 実 | 110 | → | 0.0% | 0.0% | -566 | ↑ | +20.2% | +15.1% | -573 | ↑ | +19.5% | +14.1% | -572 | ↑ | +19.8% | +14.5% |
| 2020.06 | 2020/05/13 | Q3予 | 110 | → | 0.0% | 0.0% | -709 | → | 0.0% | -6.3% | -712 | → | 0.0% | -6.7% | -713 | → | 0.0% | -6.6% |
| 2020.06 | 2020/02/12 | Q2予 | 110 | → | 0.0% | 0.0% | -709 | ↑ | +1.5% | -6.3% | -712 | → | 0.0% | -6.7% | -713 | → | 0.0% | -6.6% |
| 2020.06 | 2020/01/27 | 修正予 | 110 | → | 0.0% | 0.0% | - | - | - | - | -712 | ↑ | +1.5% | -6.7% | -713 | ↑ | +1.5% | -6.6% |
| 2020.06 | 2019/12/03 | 修正予 | 110 | → | 0.0% | 0.0% | - | - | - | - | -723 | → | 0.0% | -8.4% | -724 | → | 0.0% | -8.2% |
| 2020.06 | 2019/12/02 | 修正予 | 110 | → | 0.0% | 0.0% | -720 | ↓ | -7.9% | -7.9% | -723 | ↓ | -8.4% | -8.4% | -724 | ↓ | -8.2% | -8.2% |
| 2020.06 | 2019/11/12 | Q1予 | 110 | → | 0.0% | 0.0% | -667 | → | 0.0% | 0.0% | -667 | → | 0.0% | 0.0% | -669 | → | 0.0% | 0.0% |
| 2020.06 | 2019/08/13 | 当初予 | 110 | - | - | - | -667 | - | - | - | -667 | - | - | - | -669 | - | - | - |
| 2019.06 | 2019/08/13 | 実 | 115 | → | 0.0% | 0.0% | -533 | ↑ | +12.8% | +37.4% | -534 | ↑ | +12.3% | +37.3% | -456 | ↑ | +14.0% | +46.5% |
| 2019.06 | 2019/05/14 | Q3予 | 115 | → | 0.0% | 0.0% | -611 | → | 0.0% | +28.2% | -609 | → | 0.0% | +28.4% | -530 | → | 0.0% | +37.8% |
| 2019.06 | 2019/02/12 | Q2予 | 115 | → | 0.0% | 0.0% | -611 | → | 0.0% | +28.2% | -609 | → | 0.0% | +28.4% | -530 | → | 0.0% | +37.8% |
| 2019.06 | 2018/12/18 | 修正予 | 115 | → | 0.0% | 0.0% | -611 | ↑ | +28.2% | +28.2% | -609 | ↑ | +28.4% | +28.4% | -530 | ↑ | +37.8% | +37.8% |
| 2019.06 | 2018/11/13 | Q1予 | 115 | → | 0.0% | 0.0% | -851 | → | 0.0% | 0.0% | -851 | → | 0.0% | 0.0% | -852 | → | 0.0% | 0.0% |
| 2019.06 | 2018/08/14 | 当初予 | 115 | - | - | - | -851 | - | - | - | -851 | - | - | - | -852 | - | - | - |
| 2018.06 | 2018/08/14 | 実 | 110 | → | 0.0% | 0.0% | -539 | ↑ | +10.2% | +10.2% | -547 | ↑ | +8.8% | +8.8% | -532 | ↑ | +11.5% | +11.5% |
| 2018.06 | 2018/05/14 | Q3予 | 110 | → | 0.0% | 0.0% | -600 | → | 0.0% | 0.0% | -600 | → | 0.0% | 0.0% | -601 | → | 0.0% | 0.0% |
| 2018.06 | 2018/02/13 | Q2予 | 110 | → | 0.0% | 0.0% | -600 | → | 0.0% | 0.0% | -600 | → | 0.0% | 0.0% | -601 | → | 0.0% | 0.0% |
| 2018.06 | 2017/11/13 | Q1予 | 110 | → | 0.0% | 0.0% | -600 | → | 0.0% | 0.0% | -600 | → | 0.0% | 0.0% | -601 | → | 0.0% | 0.0% |
| 2018.06 | 2017/08/10 | 当初予 | 110 | - | - | - | -600 | - | - | - | -600 | - | - | - | -601 | - | - | - |
| 2017.06 | 2017/08/10 | 実 | 109 | ↓ | -0.9% | +3.8% | -406 | ↑ | +12.7% | +35.6% | -400 | ↑ | +14.2% | +36.5% | -419 | ↑ | +10.3% | +33.6% |
| 2017.06 | 2017/05/12 | Q3予 | 110 | → | 0.0% | +4.8% | -465 | → | 0.0% | +26.2% | -466 | → | 0.0% | +26.0% | -467 | → | 0.0% | +26.0% |
| 2017.06 | 2017/02/13 | Q2予 | 110 | → | 0.0% | +4.8% | -465 | → | 0.0% | +26.2% | -466 | → | 0.0% | +26.0% | -467 | → | 0.0% | +26.0% |
| 2017.06 | 2017/01/04 | 修正予 | 110 | ↑ | +4.8% | +4.8% | -465 | ↑ | +26.2% | +26.2% | -466 | ↑ | +26.0% | +26.0% | -467 | ↑ | +26.0% | +26.0% |
| 2017.06 | 2016/11/11 | Q1予 | 105 | → | 0.0% | 0.0% | -630 | → | 0.0% | 0.0% | -630 | → | 0.0% | 0.0% | -631 | → | 0.0% | 0.0% |
| 2017.06 | 2016/08/12 | 当初予 | 105 | - | - | - | -630 | - | - | - | -630 | - | - | - | -631 | - | - | - |
| 2016.06 | 2016/08/12 | 実 | 105 | → | 0.0% | 0.0% | -399 | ↓ | -16.3% | -16.3% | -413 | ↓ | -20.4% | -20.4% | -414 | ↓ | -20.3% | -20.3% |
| 2016.06 | 2016/05/13 | Q3予 | 105 | → | 0.0% | 0.0% | -343 | → | 0.0% | 0.0% | -343 | → | 0.0% | 0.0% | -344 | → | 0.0% | 0.0% |
| 2016.06 | 2016/02/12 | Q2予 | 105 | → | 0.0% | 0.0% | -343 | → | 0.0% | 0.0% | -343 | → | 0.0% | 0.0% | -344 | → | 0.0% | 0.0% |
| 2016.06 | 2015/11/13 | Q1予 | 105 | → | 0.0% | 0.0% | -343 | - | - | - | -343 | → | 0.0% | 0.0% | -344 | → | 0.0% | 0.0% |
| 2016.06 | 2015/08/13 | 当初予 | 105 | - | - | - | - | - | - | - | -343 | - | - | - | -344 | - | - | - |
| 2015.06 | 2015/08/13 | 実 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 2015.06 | 2015/06/16 | 修正予 | 60 | ↓ | -89.3% | -88.6% | - | - | - | - | -265 | ↓ | -202.7% | -238.7% | -266 | ↓ | -203.1% | -240.0% |
| 2015.06 | 2015/05/14 | Q3予 | 560 | → | 0.0% | +6.7% | 245 | → | 0.0% | +28.3% | 258 | → | 0.0% | +35.1% | 258 | → | 0.0% | +35.8% |
| 2015.06 | 2015/02/13 | Q2予 | 560 | → | 0.0% | +6.7% | 245 | → | 0.0% | +28.3% | 258 | → | 0.0% | +35.1% | 258 | → | 0.0% | +35.8% |
| 2015.06 | 2014/12/26 | 修正予 | 560 | ↑ | +6.7% | +6.7% | 245 | ↑ | +28.3% | +28.3% | 258 | ↑ | +35.1% | +35.1% | 258 | ↑ | +35.8% | +35.8% |
| 2015.06 | 2014/11/14 | Q1予 | 525 | → | 0.0% | 0.0% | 191 | → | 0.0% | 0.0% | 191 | → | 0.0% | 0.0% | 190 | → | 0.0% | 0.0% |
| 2015.06 | 2014/08/12 | 当初予 | 525 | - | - | - | 191 | - | - | - | 191 | - | - | - | 190 | - | - | - |
| 2014.06 | 2014/08/12 | 実 | 0 | → | - | - | -483 | - | - | - | -480 | ↓ | -0.2% | - | -376 | ↓ | -0.3% | - |
| 2014.06 | 2014/06/20 | 修正予 | 0 | → | - | - | - | - | - | - | -479 | ↓ | - | - | -375 | ↓ | - | - |
| 2014.06 | 2014/03/17 | 当初予 | 0 | - | - | - | - | - | - | - | 0 | - | - | - | 0 | - | - | - |
